Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98613745 | 9861374 | 5 | F | 2013 | 20160923 | 20140203 | 20160930 | EXP | US-AMGEN-USASP2014006361 | AMGEN | 74.00 | YR | E | F | Y | 0.00000 | 20160930 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98613745 | 9861374 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | 1043049 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 98613745 | 9861374 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | 1044819 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||||
| 98613745 | 9861374 | 3 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | 1059241 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||||
| 98613745 | 9861374 | 4 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 80 MG, QWK | 0 | 80 | MG | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98613745 | 9861374 | 1 | Psoriatic arthropathy |
| 98613745 | 9861374 | 2 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 98613745 | 9861374 | HO |
| 98613745 | 9861374 | OT |
| 98613745 | 9861374 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98613745 | 9861374 | Arthralgia | |
| 98613745 | 9861374 | Breast disorder | |
| 98613745 | 9861374 | Cardiac operation | |
| 98613745 | 9861374 | Cerebrovascular accident | |
| 98613745 | 9861374 | Condition aggravated | |
| 98613745 | 9861374 | Diplopia | |
| 98613745 | 9861374 | Dyspnoea | |
| 98613745 | 9861374 | Dystonia | |
| 98613745 | 9861374 | Fatigue | |
| 98613745 | 9861374 | Fluid retention | |
| 98613745 | 9861374 | Gait disturbance | |
| 98613745 | 9861374 | Gout | |
| 98613745 | 9861374 | Head injury | |
| 98613745 | 9861374 | Headache | |
| 98613745 | 9861374 | Heart valve incompetence | |
| 98613745 | 9861374 | Loss of control of legs | |
| 98613745 | 9861374 | Mobility decreased | |
| 98613745 | 9861374 | Nausea | |
| 98613745 | 9861374 | Pain | |
| 98613745 | 9861374 | Pruritus | |
| 98613745 | 9861374 | Psoriasis | |
| 98613745 | 9861374 | Pyrexia | |
| 98613745 | 9861374 | Thrombosis | |
| 98613745 | 9861374 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98613745 | 9861374 | 1 | 2005 | 0 |